Pharmaceutical Grade Steroids Flibanserin Female Sex Enhance CAS 167933-07-5 CAS NO.167933-07-5

Quick Details:

Product Name: Flibanserin

CAS No.: 167933-07-5

Molecular formula: C20H21F3N4O

Molecular weight: 390.4

purity: 99%

Appearance: White powder

Grade: Pharmaceutical grade

Usage: A drug being studied as a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder (HSDD)

Catagory: Pharmaceutical raw material female sex enhance

Packaging Details:1-2 kg / aluminum foil bag, 25kg/ drum, as required

Manufacturer: Carnoss

Payment Terms: T/T Bank, MoneyGram, , etc

Minimum Order Quantity: 10g

Production Capacity: 8000kg/month

Description:

1. Flibanserin is the world's first to help women improve the low libido drugs, can reduce the inhibition of sexual desire of serotonin to improve the level of stimulating sexual dopamine. The drug has been approved by the US Food and Drug Administration (FDA).

2. This product can be directly applied to the female brain control of the pleasant area, so as to restore the gradual decline of women's sexual desire. By regulating the stimulating human body system, fulapine serine helps restore the balance of libido and excitement mechanism, and ultimately guide the formation of healthy sexual performance. The effect of this drug is not immediate, need to take a few weeks before the effect can be obtained. At the same time, female Viagra also has a certain side effect, to accept the test experiment one-eighth of women appear dizziness, fatigue and drowsiness problems.

3. Fulapine and antidepressants are similar, and it affects the secretion of the brain and the mood and desire related to chemical substances. In fact, it was used as a therapeutic drug for depression before becoming a booster.And "Viagra" is different from the working principle, fludrofenas regulate the female brain of chemical substances. In addition, "Viagra" is effective for most males, and fulapine is only used in women with significantly lower sexual desire. If the medication has no sexual interest to someone, it is impossible to "wake up" by the fluoride. "Fulapine does not allow excessive sexuality," says Anita Clayton, a consultant at R & D Pharmaceuticals. "It's not aphrodisiac, it only helps to balance the chemical substances in the female brain, But it will not take more time, but it will take some time, and the medicine will have a function, and fulapine is needed for women to take it every day.

Specifications :

Items         Specification

Appearance: white crystals or crystalline powder, has a faint, characteristic odor and bitter taste

Solubility: freely soluble in water and 95%ethanol, sparingly soluble in acetic anhydride and practically insoluble in diethyl ether

pH: 3.5-4.5

Identification

1, red to dark purple color appears with(III)iron chloride

2, light red precipitate formed with reinecke salt TS

3, UV spectrum meet the reference

4, solution (1%) responds to the qualitative test for chloride

Melting point: 139-143 celcius degree

Clarity and color of solution: clear and colorless

Sulfate: 0.048%max

Heavy metals: 10ppm max; As 2ppm max

Organic acid(0.1M NaOH): 0.54ml max

Loss on drying: 0.5% max

Residue on ignition: 0.1%max

Residual organic Solvents (GC): Xylol 0.217%max; Isopropanol 0.5%max

Related substances(HPLC): Total impurity 1.5%max; Single impurity0.5%max; Free P-chloro phenoxy acetic 0.5%max

Count of bacteria: bacillus 1000/1g max; Mildew 100/1g max;Microzyme 100/1g max

Assay(C12H16CINO3.HCl,on dry basis); 98%min

Applications:

1. A new drug designed to boost sexual desire in women is controversial for some and eagerly awaited by others, but it's hit a potentially serious snag. The drug didn't boost women's desire any more than a placebo in two clinical trials. The Food and Drug Administration posted the clinical trial results on its website today in advance of a committee meeting on Friday, when a panel of experts will vote whether or not to recommend approval of the drug called flibanserin. (The FDA usually follows the recommendations of its expert panels.) Although there was a slight increase in the number of sexually satisfying events flibanserin users had each month, the FDA staff who reviewed the results said the so-called response rate isn't "particularly compelling."

2. It's called the "little pink pill," a tiny tablet that could have a huge impact on treating female sexual dysfunction. If it's approved, it would become the first drug of its kind on the market.